Approved Symbol |
Approved Name |
Location |
Source |
COX8A |
cytochrome c oxidase subunit VIIIA (ubiquitous) |
11q12-q13 |
Mapped by significant region |
ITPR1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
3p26.1 |
Mapped by CNV |
ADAM17 |
ADAM metallopeptidase domain 17 |
2p25 |
Mapped by significant region |
PLCB2 |
phospholipase C, beta 2 |
15q15 |
Mapped by PBA pathway |
CYCS |
cytochrome c, somatic |
7p21.2 |
Mapped by CNV; Mapped by significant region |
MAPK1 |
mitogen-activated protein kinase 1 |
22q11.2 |
Mapped by LD-proxy |
ATF6 |
activating transcription factor 6 |
1q22-q23 |
Mapped by CNV |
MAPT |
microtubule-associated protein tau |
17q21 |
Mapped by LD-proxy; Mapped by PBA pathway |
ITPR2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
12p11.23 |
Mapped by LD-proxy; Mapped by literature SNP |
CACNA1F |
calcium channel, voltage-dependent, L type, alpha 1F subunit |
Xp11.23 |
Mapped by LD-proxy; Mapped by PBA pathway; Mapped by literature SNP |
BAD |
BCL2-associated agonist of cell death |
11q13.1 |
Mapped by significant region |
BACE1 |
beta-site APP-cleaving enzyme 1 |
11q23-q24 |
Mapped by significant region |
COX4I1 |
cytochrome c oxidase subunit IV isoform 1 |
16q24.1 |
Mapped by significant region |
PPP3R2 |
protein phosphatase 3, regulatory subunit B, beta |
9q31 |
Mapped by significant region |
CACNA1D |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
3p14.3 |
Mapped by PBA pathway |
CACNA1S |
calcium channel, voltage-dependent, L type, alpha 1S subunit |
1q32 |
Mapped by PBA pathway |
NDUFA4L2 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
12q13.3 |
Mapped by CNV |
RYR3 |
ryanodine receptor 3 |
15q14-q15 |
Mapped by CNV; Mapped by PBA pathway |
NDUFA5 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa |
7q31.33 |
Mapped by CNV |
UQCRC2 |
ubiquinol-cytochrome c reductase core protein II |
16p12 |
Mapped by CNV; Mapped by significant region |
MAPK3 |
mitogen-activated protein kinase 3 |
16p11.2 |
Mapped by CNV |
FADD |
Fas (TNFRSF6)-associated via death domain |
11q13.3 |
Mapped by significant region |
APBB1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
11p15 |
Mapped by CNV |
NDUFS3 |
NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase) |
11p11.11 |
Mapped by LD-proxy |
NDUFV1 |
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa |
11q13 |
Mapped by significant region |
NDUFS8 |
NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase) |
11q13.2 |
Mapped by significant region |
SDHD |
succinate dehydrogenase complex, subunit D, integral membrane protein |
11q23 |
Mapped by significant region |
NDUFAB1 |
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa |
16p12.3 |
Mapped by significant region |
NDUFC2 |
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa |
11q14.1 |
Mapped by significant region |
NDUFA8 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa |
9q33.2 |
Mapped by significant region |
PLCB3 |
phospholipase C, beta 3 (phosphatidylinositol-specific) |
11q13 |
Mapped by significant region |
CAPN1 |
calpain 1, (mu/I) large subunit |
11q13 |
Mapped by significant region |